X
Our Product Range
+View All

Meropenem Injections

Offering you a complete choice of products which include Meropenem 500 Mg Injection and AVI-CEFTAJIM INJECTION.

  • Meropenem 500 Mg Injection
  • Meropenem 500 Mg Injection
  • Meropenem 500 Mg Injection
  • Meropenem 500 Mg Injection
Interested in this product?
Get Best Quote

Meropenem 500 Mg Injection

₹ 772/PieceGet Latest Price

Minimum Order Quantity: 100 Piece

Strength500mg
FormVial with WFI
BrandJM LIFESCIENCES PVTLTD
CompositionMeropenem
Route of AdministrationIV
Packaging Size1 vial + WFI
Injection SiteIV Only
Pharmacopoeia StandardIP
Also GivesPCD Pharma Franchise
UsageHuman
Injectable FormLyophilized Powder

Meropenem injection is used to treat skin and abdominal (stomach area) infections caused by bacteria and meningitis (infection of the membranes that surround the brain and spinal cord) in adults and children 3 months of age and older. Meropenem injection is in a class of medications called antibiotics.

View Complete Details

Yes, I am interested!

  • AVI-CEFTAJIM  INJECTION
  • AVI-CEFTAJIM  INJECTION
Interested in this product?
Get Best Quote

AVI-CEFTAJIM INJECTION

₹ 5,624/PieceGet Latest Price

Minimum Order Quantity: 10 Piece

Strength2 g/ 0.5 gm
Pack TypeVial
Brand NameAVI-BACTUM
Shelf Life18 Months
Quantity UnitVial
Country of OriginMade in India

Intra-abdominal Infections

Indicated in combination with metronidazole for complicated intra-abdominal infections (cIAIs) caused by the following susceptible gram-negative microorganisms: Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Enterobacter cloacae, Klebsiella oxytoca, Citrobacter freundii complex, and Pseudomonas aeruginosa

2.5 g (2 g/0.5 g) IV q8hr infused over 2 hr for 5-14 days

Urinary Tract Infections

Indicated for complicated urinary tract infections (cUTIs) including pyelonephritis caused by the following susceptible microorganisms: Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Citrobacter freundii complex, Proteus mirabilis, and Pseudomonas aeruginosa

2.5 g (2 g/0.5 g) IV q8hr infused over 2 hr for 7-14 days

Bacterial Pneumonia

Indicated for hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP) caused by the following susceptible gram negative microorganisms: Klebsiella pneumoniae, Enterobacter cloacae, Escherichia coli, Serratia marcescens, Proteus mirabilis, Pseudomonas aeruginosa, and Haemophilus influenzae

2.5 g (2 g/0.5 g) IV q8hr infused over 2 hr for 7-14 days


Dosing Considerations

To reduce the development of drug-resistant bacteria and maintain the effectiveness, use only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria

View Complete Details

Yes, I am interested!

Get in touch with us

Reach Us

JM Lifesciences Private LimitedGala No.224, Bharat Industrial Premises Co-Op Soc Ltd, Lal Bahadur Shastri Marg, Bhandup West Bhandup West Sub Post Office, Mumbai-400078, Maharashtra, India

Mr. Niraj Singh

View Mobile Number80% Call Response Rate

Send SMS
Send Email
All Rights Reserved (Terms of Use)